Tomiyasu N[au] - Search Results

Year	Number of Results
1962	1
1968	1
1998	1
2001	1
2002	2
2003	2
2004	1
2005	3
2006	7
2007	3
2009	1
2010	1
2021	1
2022	1

1

Chlamydia trachomatis proctitis.

Takedatsu H, Mitsuyama K, Yamasaki H, Itou M, Toubaru T, Tomiyasu N, Tsuruta O, Sata M. Takedatsu H, et al. Among authors: tomiyasu n. Endoscopy. 2007 Feb;39 Suppl 1:E104. doi: 10.1055/s-2006-945147. Epub 2007 Apr 18. Endoscopy. 2007. PMID: 17440854 No abstract available.

2

Transcription factor-targeted therapies in inflammatory bowel disease.

Mitsuyama K, Suzuki A, Tomiyasu N, Takaki K, Toyonaga A, Sata M. Mitsuyama K, et al. Among authors: tomiyasu n. Digestion. 2001;63 Suppl 1:68-72. doi: 10.1159/000051914. Digestion. 2001. PMID: 11173913 Review.

3

Quantitative metabolomics for dynamic metabolic engineering using stable isotope labeled internal standards mixture (SILIS).

Soma Y, Takahashi M, Fujiwara Y, Tomiyasu N, Goto M, Hanai T, Izumi Y, Bamba T. Soma Y, et al. Among authors: tomiyasu n. J Biosci Bioeng. 2022 Jan;133(1):46-55. doi: 10.1016/j.jbiosc.2021.09.009. Epub 2021 Oct 5. J Biosci Bioeng. 2022. PMID: 34620543

4

Pro-inflammatory signaling by Jun-N-terminal kinase in inflammatory bowel disease.

Mitsuyama K, Suzuki A, Tomiyasu N, Tsuruta O, Kitazaki S, Takeda T, Satoh Y, Bennett BL, Toyonaga A, Sata M. Mitsuyama K, et al. Among authors: tomiyasu n. Int J Mol Med. 2006 Mar;17(3):449-55. Int J Mol Med. 2006. PMID: 16465391

5

Activation of c-Jun N-terminal kinase (JNK) signalling in experimentally induced gastric lesions in rats.

Mitsuyama K, Tsuruta O, Matsui Y, Harada K, Tomiyasu N, Suzuki A, Takaki K, Masuda J, Handa K, Satoh Y, Bennett BL, Toyonaga A, Sata M. Mitsuyama K, et al. Among authors: tomiyasu n. Clin Exp Immunol. 2006 Jan;143(1):24-9. doi: 10.1111/j.1365-2249.2005.02959.x. Clin Exp Immunol. 2006. PMID: 16367930 Free PMC article.

6

Interleukin-10 in the pathophysiology of inflammatory bowel disease: increased serum concentrations during the recovery phase.

Mitsuyama K, Tomiyasu N, Takaki K, Masuda J, Yamasaki H, Kuwaki K, Takeda T, Kitazaki S, Tsuruta O, Sata M. Mitsuyama K, et al. Among authors: tomiyasu n. Mediators Inflamm. 2006;2006(6):26875. doi: 10.1155/MI/2006/26875. Mediators Inflamm. 2006. PMID: 17392581 Free PMC article.

7

Increased circulating concentrations of growth-related oncogene (GRO)-alpha in patients with inflammatory bowel disease.

Mitsuyama K, Tsuruta O, Tomiyasu N, Takaki K, Suzuki A, Masuda J, Yamasaki H, Toyonaga A, Sata M. Mitsuyama K, et al. Among authors: tomiyasu n. Dig Dis Sci. 2006 Jan;51(1):173-7. doi: 10.1007/s10620-006-3104-4. Dig Dis Sci. 2006. PMID: 16416232

8

Bifidogenic growth stimulator for the treatment of active ulcerative colitis: a pilot study.

Suzuki A, Mitsuyama K, Koga H, Tomiyasu N, Masuda J, Takaki K, Tsuruta O, Toyonaga A, Sata M. Suzuki A, et al. Among authors: tomiyasu n. Nutrition. 2006 Jan;22(1):76-81. doi: 10.1016/j.nut.2005.04.013. Epub 2005 Oct 12. Nutrition. 2006. PMID: 16226014 Clinical Trial.

9

STAT3 activation via interleukin 6 trans-signalling contributes to ileitis in SAMP1/Yit mice.

Mitsuyama K, Matsumoto S, Rose-John S, Suzuki A, Hara T, Tomiyasu N, Handa K, Tsuruta O, Funabashi H, Scheller J, Toyonaga A, Sata M. Mitsuyama K, et al. Among authors: tomiyasu n. Gut. 2006 Sep;55(9):1263-9. doi: 10.1136/gut.2005.079343. Epub 2006 May 8. Gut. 2006. PMID: 16682432 Free PMC article.

10

Development of granulocyte and monocyte adsorptive apheresis in the rat dextran sodium sulfate-induced colitis model.

Tomiyasu N, Mitsuyama K, Suzuki A, Masuda J, Yamasaki H, Kuwaki K, Takaki K, Kitazaki S, Sata M. Tomiyasu N, et al. Methods Find Exp Clin Pharmacol. 2007 May;29(4):265-8. doi: 10.1358/mf.2007.29.4.1075361. Methods Find Exp Clin Pharmacol. 2007. PMID: 17609738

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results